Long-term, Safety, Tolerability and Efficacy Study of AFQ056 in Adult Patients With Fragile X Syndrome
Status:
Terminated
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to generate long-term safety, tolerability and efficacy data for
AFQ056 in eligible adult patients with FXS who have participated in the CAFQ056A2212
(NCT01253629).study and patients who have participated in the previous proof-of-concept study
CAFQ056A2204 (NCT00718341).